Patients with type 2 diabetes who were treated with metformin had a 30% reduction in risk for total knee and total hip replacement, compared with patients who did not receive the drug.
/PRNewswire/ The global orthopedic navigation systems market is estimated to reach US$ 197.9 Million in 2022. Sales are poised to expand at 17% CAGR between.
Optical Navigation Systems Demand to Grow at Stupendous CAGR of 19% Through 2027 Fact.MR's latest report on the global orthopedic navigation systems market provides a 5-year forecast through